alpha2B-AR Activators
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Xylazine Hydrochloride | 23076-35-9 | sc-220393 | 1 g | $57.00 | 1 | |
Xylazine Hydrochloride functions as an alpha2B-adrenergic receptor agonist, exhibiting a distinct binding affinity that influences receptor dynamics. Its molecular structure facilitates unique hydrogen bonding and hydrophobic interactions, which stabilize receptor-ligand complexes. This compound is known for its modulation of neurotransmitter release, impacting downstream signaling pathways. The kinetics of Xylazine Hydrochloride reveal a rapid onset of action, with potential implications for receptor internalization and desensitization processes. | ||||||
Guanabenz acetate | 23256-50-0 | sc-203590 sc-203590A sc-203590B sc-203590C sc-203590D | 100 mg 500 mg 1 g 10 g 25 g | $102.00 $468.00 $832.00 $4162.00 $7283.00 | 2 | |
Guanabenz acetate acts as an alpha2B-adrenergic receptor agonist, characterized by its selective binding that alters receptor conformation. The compound engages in specific electrostatic interactions, enhancing its affinity for the receptor. Its unique molecular architecture promotes distinct allosteric modulation, influencing downstream signaling cascades. The reaction kinetics suggest a prolonged engagement with the receptor, potentially affecting desensitization and regulatory feedback mechanisms. | ||||||
Xylometazoline hydrochloride | 1218-35-5 | sc-255719 | 5 g | $164.00 | ||
Xylometazoline hydrochloride functions as an alpha2B-adrenergic receptor agonist, exhibiting a unique binding profile that stabilizes receptor dimers. Its molecular structure facilitates hydrophobic interactions, enhancing receptor affinity and specificity. The compound's kinetic behavior indicates rapid onset and a sustained interaction, influencing receptor desensitization pathways. Additionally, its stereochemistry plays a crucial role in modulating receptor activity, impacting downstream signaling dynamics. | ||||||
Terazosin hydrochloride | 63074-08-8 | sc-204337 | 50 mg | $117.00 | ||
Terazosin hydrochloride acts as an alpha2B-adrenergic receptor antagonist, characterized by its ability to disrupt receptor-mediated signaling cascades. The compound's unique conformation allows for selective binding, leading to altered receptor conformational states. Its interaction with the receptor involves both ionic and hydrophobic forces, which modulate the receptor's activity. The kinetics of Terazosin suggest a gradual dissociation, influencing downstream cellular responses and receptor recycling processes. | ||||||
Medetomidine hydrochloride | 86347-15-1 | sc-204073 sc-204073A | 10 mg 50 mg | $123.00 $495.00 | 2 | |
Medetomidine hydrochloride functions as an alpha2B-adrenergic receptor agonist, exhibiting a high affinity for the receptor that triggers inhibitory G-protein signaling pathways. Its structural features facilitate specific hydrogen bonding and hydrophobic interactions, stabilizing the receptor in an active conformation. The compound's kinetics reveal a rapid onset of action, with a notable duration of receptor engagement, impacting neurotransmitter release and synaptic transmission dynamics. | ||||||
p-Iodoclonidine hydrochloride | 108294-53-7 | sc-257955 | 25 mg | $45.00 | ||
p-Iodoclonidine hydrochloride acts as a selective alpha2B-adrenergic receptor agonist, characterized by its unique iodine substitution that enhances lipophilicity and receptor binding affinity. This compound engages in distinct electrostatic interactions, promoting conformational changes in the receptor. Its reaction kinetics indicate a swift association with the receptor, leading to prolonged modulation of intracellular signaling cascades, particularly in the inhibition of adenylate cyclase activity. | ||||||